
Keywords: G6Pase α; glucose-6-phosphatase α; G6PC; glucose-6-phosphatase α catalytic subunit; GSDIa; glycogen storage disease type Ia; G6P; glucose-6-phosphate; mTOR; mammalian target of rapamycin; AMPK; 5' AMP-activated protein kinase; ULK1; Unc51-like kinase